IDEAYA Biosciences (IDYA) Shares Outstanding (Weighted Average) (2018 - 2026)

IDEAYA Biosciences has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $88.7 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $88.7 million, changed 0.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.7 million (changed 0.39% YoY), and the FY2025 annual result was $88.5 million, up 8.33% from the prior year.
• Shares Outstanding (Weighted Average) came in at $88.7 million for Q1 2026 at IDEAYA Biosciences, roughly flat from $88.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $88.7 million in Q1 2026 to a low of $38.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $75.1 million (2024), against an average of $66.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 56.95% in 2024 and rose 0.39% in 2026, its largest moves.
• IDEAYA Biosciences' Shares Outstanding (Weighted Average) stood at $41.4 million in 2022, then surged by 38.79% to $57.5 million in 2023, then jumped by 42.0% to $81.7 million in 2024, then advanced by 8.33% to $88.5 million in 2025, then grew by 0.24% to $88.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $88.7 million (Q1 2026), $88.5 million (Q4 2025), and $88.5 million (Q3 2025), per Business Quant data.